Consider Every Trial as a TeleTrial

TOGA Podcast

English - April 30, 2022 11:45 - 19 minutes - 35.4 MB
Medicine Health & Fitness lung cancer oncology toga Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: EGFR Update: Improving Outcomes in EGFR-Mutated Non-Small-Cell Cancer

Next Episode: Practical smoking cessation advice for health care providers

Barriers and facilitators and a unique insight into the patient benefits are discussed between Alexandra, patient advocate, teletrials participant and lung cancer survivor, Sabe Sabesan, medical oncologist from the ICON Cancer Centre in Townsville and co-chair of the Australian Teletrial program and the initial teletrials pilot in 2017-2020, and Craig Underhill, medical oncologist from Border Medical Oncology and Haematology in Albury/Wodonga. Incentive funding and harmonising governance requirements for TeleTrials in Australia will help solve many of these issues and continue to transform the way trials are managed. The benefits for patients and their families are clear and positively impact the future of trials in Australia.

Resources: https://wiki.cancer.org.au/australia/COSA:Teleoncology

https://www.digitalhealth.gov.au/healthcare-providers/initiatives-and-programs/telehealth

https://thoraciconcology.org.au/teletrials/

Supported by Takeda

Disclaimer: The opinions, beliefs and viewpoints expressed by the various authors and participants contained in this message do not necessarily reflect the opinions, beliefs and viewpoints of TOGA or official policies of TOGA. Dosage & administration of any treatments mentioned during TOGA medical education may differ between Regions. Please refer to your local prescribing information for further details.